NIH-funded research Fellowship grant

Understanding how B cells recognize antigens better

Official title: Regulation of B cell receptor avidity to organize antigen recognition

Funded at Harvard Medical School · NIH-10993377 · Data updated 2026-11-12

This study is looking at how the number of spots on B cell receptors helps them recognize germs better, which could help us understand how our immune system gets stronger and picks the best antibodies to fight infections.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionHarvard Medical School
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 30, 2024
Project endSeptember 29, 2025
Funding year2024
Award (this year)$43,456
NIH project number1F31AI186217-01
Project IDNIH-10993377 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with immune system disorders or those interested in understanding their immune responses better.

Less likely to help

Patients with stable immune conditions who do not require further investigation into their B cell function may not benefit from this research.

What this research studies

This research investigates how the number of binding sites on B cell receptors affects their ability to recognize antigens. By using a specially designed tool to measure these binding sites, the study aims to understand how B cells develop and optimize their response to infections. The approach focuses on the developmental stages of B cells, examining how their receptor binding capabilities change and improve over time. This could lead to insights into how the immune system selects the most effective antibodies during an immune response.

Why it matters

Potential benefit: If successful, this research could enhance our understanding of immune responses, potentially leading to improved vaccines and therapies for various diseases.

How similar studies have gone: Previous research has shown that understanding B cell receptor dynamics can lead to significant advancements in immunology, suggesting this approach has the potential for success.

Where this research is happening

  • Harvard Medical School
    Boston, United States
    Active

Researchers

  • Principal investigator: Rosado, Victoria Celine — Harvard Medical School
  • Study coordinator: Rosado, Victoria Celine

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.